Skip to main content

Articles

Page 1 of 16

  1. There is substantial evidence to support the use of several methods for preventing deep-vein thrombosis (DVT) following intracerebral hemorrhage (ICH). However, the extent to which these measures are implement...

    Authors: Ran Zhang, Weige Sun, Yana Xing, Yongjun Wang, Zixiao Li, Liping Liu, Hongqiu Gu, Kaixuan Yang, Xin Yang, Chunjuan Wang, Qingbo Liu, Qian Xiao and Weixin Cai
    Citation: Thrombosis Journal 2024 22:22
  2. This study aimed to analyze the independent risk factors contributing to preoperative DVT in TKA and constructed a predictive nomogram to accurately evaluate its occurrence based on these factors.

    Authors: Zehua Wang, Xingjia Mao, Zijian Guo, Guoyu Che, Changxin Xiang and Chuan Xiang
    Citation: Thrombosis Journal 2024 22:21
  3. Inherited thrombophilia (IT) has a complex pathophysiology and is associated with recurrent miscarriage (RM) by causing placental insufficiency and inhibiting fetal development. However, thrombophilia screenin...

    Authors: Ayman A. Najjar, Imam Hassouna, Mahmoud A. Srour, Hany M. Ibrahim, Randa Y. Assi and Heba M. Abd El Latif
    Citation: Thrombosis Journal 2024 22:20
  4. Antithrombin (AT) is an important anticoagulant in hemostasis. We describe here the characterization of a novel AT mutation associated with clinically relevant thrombosis. A pair of sisters with confirmed type...

    Authors: Maximilian Ruf, Sarah Cunningham, Alexandra Wandersee, Regine Brox, Susanne Achenbach, Julian Strobel, Holger Hackstein and Sabine Schneider
    Citation: Thrombosis Journal 2024 22:19
  5.  We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics. Antithrombin (AT...

    Authors: Takao Kobayashi, Kazuko Sugiura, Toshiyuki Ojima, Mariko Serizawa, Kyuya Hirai and Eriko Morishita
    Citation: Thrombosis Journal 2024 22:18
  6. Patients with venous thromboembolism (VTE) comorbid renal insufficiency (RI) are at higher risk of bleeding and thrombosis. Recommendations in guidelines on anticoagulation therapy for those patients remain am...

    Authors: Shuangshuang Ma, Guohui Fan, Feiya Xu, Xiaomeng Zhang, Yinong Chen, Yuzhi Tao, Yishan Li, Yanshuang Lyu, Peiran Yang, Dingyi Wang, Zhenguo Zhai and Chen Wang
    Citation: Thrombosis Journal 2024 22:17
  7. Causes of death after first time community-acquired venous thromboembolism (VTE) diagnosed in unselected patients at the emergency department (ED) was investigated.

    Authors: Frida Lonnberg, Andreas Roos, Maria Farm, André Heurlin, Mantas Okas, Bruna Gigante and Anwar J Siddiqui
    Citation: Thrombosis Journal 2024 22:16
  8. Identifying venous thromboembolism (VTE) is challenging for patients with cardiovascular diseases due to similar clinical presentation. Most hospital-acquired VTE events are preventable, whereas the implementa...

    Authors: Qin Luo, Xin Li, Zhihui Zhao, Qing Zhao, Zhihong Liu and Weixian Yang
    Citation: Thrombosis Journal 2024 22:15
  9. Microbial infection has been associated with thrombogenesis. This study aimed to detect bacterium-specific genes and other signatures in thrombi from patients with acute ischemic stroke and to relate these sig...

    Authors: Xiaoke Wang, Jie Gao, Yantong Chen, Xiaohao Zhang, Zhengze Dai, Qiliang Dai, Mengna Peng, Lulu Xiao, Xuerong Jia, Haodi Cai, Tao Mou, Xiang Li and Gelin Xu
    Citation: Thrombosis Journal 2024 22:14
  10. A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the cardiac ward within a one-month period due to escalating ch...

    Authors: Ai Phi Thuy Ho, Eirik Tjønnfjord, Oliver Meyerdierks and Ellen Elisabeth Brodin
    Citation: Thrombosis Journal 2024 22:13
  11. Sepsis is a global public health burden. Deep vein thrombosis (DVT) is the third most common cause of death from cardiovascular disease after heart attacks and strokes. We designed this experiment to investiga...

    Authors: Lu Wang, Xudong Ma, Yujie Chen, Sifa Gao, Wei Pan, Jieqing Chen, Longxiang Su, Huaiwu He, Yun Long, Chang Yin and Xiang Zhou
    Citation: Thrombosis Journal 2024 22:11
  12. Disseminated intravascular coagulation (DIC) syndrome is a highly lethal condition characterized by the complication of multiple organ damage. Although the effects of combined antithrombin (AT) and recombinant...

    Authors: Takaaki Totoki, Yuto Makino, Kazuma Yamakawa, Hiroyuki Koami, Takeshi Wada, Takashi Ito and Toshiaki Iba
    Citation: Thrombosis Journal 2024 22:10
  13. Oxidative stress is an imbalance between the body’s reactive oxygen species and antioxidant defense mechanisms. Oxidative stress is involved in the development of several cardiovascular diseases, such as pulmo...

    Authors: Jingchao Yang, Jinzhu Xu, Shuanglan Xu, Zeqin Fan, Chenshao Zhu, Jianyuan Wan, Jiao Yang and Xiqian Xing
    Citation: Thrombosis Journal 2024 22:9
  14. Obstructive shock is extremely rare in clinical practice and is caused by acute blood flow obstruction in the central vessels of either the systemic or pulmonary circulation. Utilizing inferior vena cava filte...

    Authors: ShuTing Gao, YunFei Chen, YaTing Huang, YiPing Dang and YiQing Li
    Citation: Thrombosis Journal 2024 22:7
  15. The prothrombotic state is a common abnormality in patients with coronavirus disease 2019 (COVID-19). However, there is controversy over the use of anticoagulants, especially oral anticoagulants (OAC) due to l...

    Authors: Xing Wang, Wuqian Chen, Jiulin Guo, Xingyu Qiu, Chao You and Lu Ma
    Citation: Thrombosis Journal 2024 22:5
  16. Primary pulmonary artery sarcoma (PAS) is an extremely rare malignant tumor with a poor prognosis. The clinical manifestations of PAS are diverse, including dyspnea, chest pain, cough, and hemoptysis. The poor...

    Authors: Zhiyue Liu, Lili Fan, Shichu Liang, Zhong Wu and He Huang
    Citation: Thrombosis Journal 2024 22:4
  17. Deep venous thrombosis (DVT) is the common clinical cardiovascular disease, and easily develops into post-thrombotic syndrome (PTS). The study aimed to examine the clinical value of long non-coding RNA NORAD gene...

    Authors: Kun Zhou, Na Li, Jia Qi, Pingping Tu, Yan Yang and Hui Duan
    Citation: Thrombosis Journal 2024 22:3
  18. The benefit-risk profile of direct oral anticoagulants (DOAC) therapy in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) has not been well established yet. This study aimed to eval...

    Authors: Si-qi Lyu, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing-hui Shao and Yan-min Yang
    Citation: Thrombosis Journal 2024 22:2
  19. Hereditary predisposition play an important role in thrombosis, especially in younger patients. Here we studied a young patient who experienced three different episodes of severe thromboses, some of which were...

    Authors: Xuqian Wei, Houliang Zhang, Weibin Chen, Jian Zhang and Jing Dai
    Citation: Thrombosis Journal 2024 22:1
  20. Optimising periprocedural management of direct oral anticoagulation in patients with atrial fibrillation on chronic treatment undergoing major surgeries is an important aspect of balancing the risk of surgery-...

    Authors: Christian von Heymann, Martin Unverdorben, Paolo Colonna, Amparo Santamaria, Manish Saxena, Thomas Vanassche, Sabine Köhler, Amanda P. Borrow, James Jin and Cathy Chen
    Citation: Thrombosis Journal 2023 21:124
  21. Congenital antithrombin deficiency is an autosomal dominant disease that results in deep venous thrombosis and pulmonary embolism, which is mainly caused by mutations in the antithrombin gene (SERPINC1). Since SE...

    Authors: Yuwen Huang, Yinling Wang, Xiaoli Wang, Jue Liu, Bing Luo and Yuanmei Gao
    Citation: Thrombosis Journal 2023 21:123
  22. Von Willebrand factor (VWF) and factor VIII (FVIII) complex play a pivotal role in hemostasis. A deficiency or defect of VWF causes von Willebrand disease (VWD). Recombinant (r)VWF product has proved to be eff...

    Authors: Hiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara and Keiji Nogami
    Citation: Thrombosis Journal 2023 21:122
  23. Available evidence to identify factors independently associated with failed thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to evaluate in hospitalized patients, which clin...

    Authors: Santiago Grillo Pérez, Paula Ruiz-Talero and Oscar Mauricio Muñoz Velandia
    Citation: Thrombosis Journal 2023 21:120
  24. Thrombotic Microangiopathy (TMA) is a syndrome characterized by the presence of anemia, thrombocytopenia and organ damage and has multiple etiologies. The primary aim is to develop an algorithm to classify TMA...

    Authors: Vanessa Vilani Addad, Lilian Monteiro Pereira Palma, Maria Helena Vaisbich, Abner Mácola Pacheco Barbosa, Naila Camila da Rocha, Marilia Mastrocolla de Almeida Cardoso, Juliana Tereza Coneglian de Almeida, Monica AP de Paula de Sordi, Juliana Machado-Rugolo, Lucas Frederico Arantes and Luis Gustavo Modelli de Andrade
    Citation: Thrombosis Journal 2023 21:119
  25. There are limited data about the clinical benefits and harm of direct oral anticoagulants (DOACs) in stroke prevention in patients with atrial fibrillation (AF) complicated with anemia or thrombocytopenia.

    Authors: Wenlin Xu, Jiana Chen, Shuyi Wu, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin, Yanxia Zhang…
    Citation: Thrombosis Journal 2023 21:118
  26. Mixed phenotype acute leukaemia (MPAL) is associated with worse overall survival, compared with other acute leukaemias in adults. Lack of clear treatment guidelines makes the therapy challenging. ALL-like indu...

    Authors: Wojciech Lizurej, Łukasz Mazurkiewicz, Michał Kowalski, Sylwia Szydłowska, Michał Wyrzykowski and Krzysztof Lewandowski
    Citation: Thrombosis Journal 2023 21:117
  27. Cerebral venous sinus thrombosis (CVST) can cause sinus obstruction and stenosis, with potentially fatal consequences. High-resolution magnetic resonance imaging (HRMRI) can diagnose CVST qualitatively, althou...

    Authors: Yu-zhou Chang, Hao-Yu Zhu, Yu-Qi Song, Xu Tong, Xiao-Qing Li, Yi-Long Wang, Ke-Hui Dong, Chu-Han Jiang, Yu-Peng Zhang and Da-Peng Mo
    Citation: Thrombosis Journal 2023 21:116
  28. Alpha-thalassemia (α-thalassemia) is one of the most common monogenic diseases in Saudi Arabia and is associated with significant morbidity. Premarital testing programs in Saudi Arabia reduce the burden of hem...

    Authors: Hayaa M. Alhuthali, Eman F. Ataya, Alaa Alsalmi, Triq E Elmissbah, Khalaf F Alsharif, Hind A. Alzahrani, Ahad Amer Alsaiari, Mamdouh Allahyani, Amal F. Gharib, Husam Qanash, Heba M. Elmasry and Doha Elsayed Hassanein
    Citation: Thrombosis Journal 2023 21:115
  29. Systemic lupus erythematosus (SLE) patients have an increased risk of cardiovascular disease and thrombotic events, and the presence of antiphospholipid antibodies further raises the risk of these complication...

    Authors: Chiara Schiavi, Luca Marri and Simone Negrini
    Citation: Thrombosis Journal 2023 21:113
  30. Disseminated intravascular coagulation (DIC) is a common and critical complication in sepsis. Antithrombin activity, which is considered a biomarker for disease severity, was measured in septic DIC treated wit...

    Authors: Toshiaki Iba, Tomoki Tanigawa, Hideo Wada and Jerrold H. Levy
    Citation: Thrombosis Journal 2023 21:112
  31. Venous thromboembolic events (VTE) are a significant cause of morbidity and mortality following traumatic injury. We examined demographic characteristics, chemoprophylaxis, and outcomes of VTE patients with bl...

    Authors: Camille Lineberry, Dimitri Alexis, Ambika Mukhi, Kevin Duh, Mathew Tharakan, James A. Vosswinkel and Randeep S. Jawa
    Citation: Thrombosis Journal 2023 21:111
  32. Current clinical practice guidelines lack explicit guidance on the indications and appropriate timing of venous ultrasound (US) in lower extremity deep vein thrombosis (DVT) follow-up. Moreover, abnormal findi...

    Authors: Farooq Akram, Bingwen Eugene Fan, Chuen Wen Tan, Wey Chyi Teoh, Paolo Prandoni and Eng Soo Yap
    Citation: Thrombosis Journal 2023 21:110
  33. Previous cohort studies have shown that exogenous sex hormone use, such as testosterone replacement therapy and oestrogen-containing contraceptives, can increase the risk of venous thromboembolism (VTE). Howev...

    Authors: Shuping Wang, Yongxiang Wang, Ming Bai, Yu Peng, Dan Zhou, Peng Lei, Binpeng Zhou, Piyi Zhang and Zheng Zhang
    Citation: Thrombosis Journal 2023 21:109
  34. Hemophilia A (HEMA) is an X-linked bleeding disorder caused by reduced/absent coagulation factor VIII expression, as a result of pathogenic variants in the F8 gene. Preimplantation prevention of HEMA should ideal...

    Authors: Minh Tam Nguyen, Thanh Tung Nguyen, Duy Bac Nguyen, Thi Mai Nguyen, Kim Ngan Nguyen, Van Nhat Minh Ngo, Van Dieu Nguyen, Ngoc Anh Tran, Mulias Lian, Arnold S. C. Tan, Samuel S. Chong and Tien Truong Dang
    Citation: Thrombosis Journal 2023 21:108
  35. Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by increased platelet destruction and impaired thrombopoiesis. The changes in platelet indices depend on the morphology and volu...

    Authors: Pengcheng Xu, Shouqing Han, Ming Hou, Yajing Zhao and Miao Xu
    Citation: Thrombosis Journal 2023 21:107
  36. Deep venous thrombosis (DVT) prediction after total hip and knee arthroplasty remains challenging. Early diagnosis and treatment of DVT are crucial. This research aimed to develop a nomogram for early DVT pred...

    Authors: Zhencan Lin, Hao Sun, Deng Li, Zhiqing Cai, Zhencheng Huang, Fangzhou Liu, Meiyi Chen, Yimin Wang, Jie Xu and Ruofan Ma
    Citation: Thrombosis Journal 2023 21:106
  37. Individuals with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) are at risk of developing venous thromboembolism (VTE), a serious complication. There is no established clinical model for predic...

    Authors: Xiaozhe Li, Xiuli Sun, Baijun Fang, Yun Leng, Fangfang Sun, Yaomei Wang, Qing Wang, Jie Jin, Min Yang, Bing Xu, Zhihong Fang, Lijuan Chen, Zhi Chen, Qimei Yang, Kejie Zhang, Yinhai Ye…
    Citation: Thrombosis Journal 2023 21:105
  38. Fluorogenic thrombin generation (TG) is a global hemostasis assay that provides an overall representation of hemostasis potential. However, the accurate detection of thrombin activity in plasma may be affected...

    Authors: Joseph W. Jackson, Colin Longstaff, Samuel A. Woodle, William C. Chang and Mikhail V. Ovanesov
    Citation: Thrombosis Journal 2023 21:104
  39. R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or a...

    Authors: Lei Li, Jian Li, Xi Wu, Wenman Wu, Qiulan Ding, Baohua Qian and Xuefeng Wang
    Citation: Thrombosis Journal 2023 21:103
  40. Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by low platelet count and bleeding manifestations. However, some patients also suffered from atherosclerosis or even infarction....

    Authors: Shouqing Han, Hui Lu, Yafei Yu, Xinguang Liu, Fangmiao Jing, Liang Wang, Yajing Zhao and Ming Hou
    Citation: Thrombosis Journal 2023 21:102
  41. Patients with critical COVID-19 have a high risk of thromboembolism, but intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-weight heparins can be monitored by measuri...

    Authors: Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg and Maria Cronhjort
    Citation: Thrombosis Journal 2023 21:101
  42. In case of heparin-induced thrombocytopenia (HIT), the switch to a non-heparin anticoagulant is mandatory, at a therapeutic dose. Such a treatment has limitations though, especially for patients with renal and...

    Authors: Antoine Barocas, Philippe Savard, Audrey Carlo, Thomas Lecompte and Emmanuel de Maistre
    Citation: Thrombosis Journal 2023 21:100
  43. Although the atherogenic index of plasma (AIP) based on a single measurement is a known risk factor for cardiovascular disease (CVD), little is known about whether changes in AIP over time are related to incid...

    Authors: Dong-Wook Chun, Yae-Ji Lee, Jun-Hyuk Lee and Ji-Won Lee
    Citation: Thrombosis Journal 2023 21:99

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

    Members of APSTH are entitled to a 15% discount on the article processing charge.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2022 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    121 days submission to accept (Median)

    2022 Usage 
    617,320 downloads
    3,882 Altmetric mentions